Drug Combinations: Tests and Analysis with Isoboles

Ronald J. Tallarida1

1 Temple University School of Medicine, Philadelphia, Pennsylvania
Publication Name:  Current Protocols in Pharmacology
Unit Number:  Unit 9.19
DOI:  10.1002/0471141755.ph0919s72
Online Posting Date:  March, 2016
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Described in this unit are experimental and computational methods to detect and classify drug interactions. In most cases, this relates to two drugs or compounds with overtly similar effects, e.g., two analgesics or two anti‐hypertensives. From the dose‐response data of the individual drugs, it is possible to generate a curve, the isobole, which defines all dose combinations that are expected to yield a specified effect. The theory underlying the isobole involves the calculation of doses of drug A that are effectively equivalent to doses of drug B with that equivalence determining whether the isobole is linear or nonlinear. In either case, the isobole allows for a comparison with actual combination effects making it possible to determine whether the interaction is synergistic, additive, or sub‐additive. Actual as well as illustrative data are employed to demonstrate experimental design and data analysis. © 2016 by John Wiley & Sons, Inc.

Keywords: drug synergism; additivity; sub‐additivity

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Experimental Steps
  • Curved Isobole
  • Site‐Site Analysis
  • Opposite Effects
  • Summary and Discussion
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
  Benamar, K., Yondorf, M., Meissler, J., Geller, E., Tallarida, R.J., Eistenstein, T, and Adler, M.W. 2007. A novel role of cannabinoids: Implications in the fever‐induced by bacterial lipopolysaccharides. J. Pharmacol. Exp. Ther. 320:1127‐1133. doi: 10.1124/jpet.106.113159.
  Berenbaum, M.C. 1989. What is Synergy? Pharmacol. Rev. 41:93‐144.
  Bliss, C.I. 1939. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26:585‐615. doi: 10.1111/j.1744-7348.1939.tb06990.x.
  Chou, T.C. and Talalay, P. 1984. Quantitative analysis of dose‐effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enz. Regul. 22:27‐55. doi: 10.1016/0065-2571(84)90007-4.
  Clark, A.J. 1926. The relation between acetylcholine and muscle cells. J. Physiol. 61:530‐546. doi: 10.1113/jphysiol.1926.sp002314.
  Gessner, P.K. and Cabana, B.E. 1970. A study of the hypnotic and of the toxic effects of chloral hydrate and ethanol. J. Pharmacol. Exp. Ther. 174:247‐259.
  Grabovsky, Y. and Tallarida, R.J. 2004. Isobolographic analysis for combinations of a full and partial agonist: Curved isoboles. J. Pharmacol. Exp. Ther. 310:981‐986. doi: 10.1124/jpet.104.067264.
  Loewe, S. 1927. Die mischiarnei klin. Wochenschr. 6:1077‐1085. doi: 10.1007/BF01890305.
  Loewe, S. 1928. Die quantitativen probleme der pharmakologie. Ergebn. Physiol. 27:47‐187. doi: 10.1007/BF02322290.
  Loewe, S. 1953. The problem of synergism and antagonism of combined drugs. Arzneimittel‐Forschung 3:285‐290.
  Loewe, S. 1957. Antagonism and antagonists. Pharmacol. Rev. 9:237‐242.
  Raffa, R.B., Stone, D.J., and Tallarida, R.J. 2000. Discovery of “self‐synergistic” spinal/supraspinal antinociception produced by acetaminophen (paracetamol). J. Pharmacol. Exp. Ther. 295:291‐294.
  Rawls, S.M., Cowan, A., Tallarida, R.J., Geller, E.B., and Adler, M.W. 2002. NMDA antagonists and WIN 55212‐2, a cannabinoid antagonist, interact to produce synergistic hypothermia. J. Pharmacol. Exp. Ther. 303:395‐402. doi: 10.1124/jpet.102.037473.
  Tallarida, R.J. 2006. An overview of drug combination analysis with isobolograms. Perspectives in pharmacology. J. Pharmacol. Exp. Ther. 319:1‐7. doi: 10.1124/jpet.106.104117.
  Tallarida, R.J. 2012. Revisiting the isobole and related quantitative methods for assessing drug synergism, perspective in pharmacology. J. Pharmacol. Exp. Ther. 342:2‐8. doi: 10.1124/jpet.112.193474.
  Tallarida, R.J. and Raffa, R.B. 1996. Testing for synergism over a range of fixed ratio drug combinations: Replacing the isobologram. Life Sci. 58:PL23‐28.
  Tallarida, R.J. and Raffa, R.B. 2010. The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations. Pharmacol. Ther. 127:165‐174. doi: 10.1016/j.pharmthera.2010.04.011.
  Tallarida, R.J., Cowan, A., and Raffa, R.B. 2003. Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice. J. Pharmacol. Exp. Ther. 307:699‐704. doi: 10.1124/jpet.103.054320.
  Woolverton, W.L., Wang, Z., Vasterling, T., and Tallarida, R.J. 2008. Self‐administration of cocaine‐remifentanil mixtures by monkeys: An isobolographic analysis. Psychopharmacology 198:387‐394. doi: 10.1007/s00213-008-1152-5.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library